
Types of Studies
We start with your research objectives to advise you on selecting the most appropriate techniques and study design, and to provide you with interactive results that make them easier to interpret.
What would you like to say?
Choose the type of study that best fits your project. For each one, we explain how we approach it, what to consider in the design, and what results you’ll receive.
Gene Expression Profiles
Which genes change their expression across different conditions, treatments, or phenotypes?
We quantify gene expression in each sample and identify genes with significant changes, from whole tissues down to individual cells.
How We Approach It
Study Design
- Replies
- At least 3 biological replicates per treatment
- Sample
- Total RNA ≥500 ng, RIN ≥7 · FFPE: DV200 ≥70%
- Depth
- 40 M readings in
mRNA-Seq and 60 M in totalRNA-Seq - Deadline
15–20 business days until the FASTQ files are delivered
Biomarker Discovery
Which molecules distinguish between sample groups or have diagnostic, prognostic, or predictive value?
We are looking for signatures in the transcriptome, the circulating proteome, and the integration of various omics data from the same cohort.
How We Approach It
Study Design
- Replies
- At least 3 samples per condition in
RNA-Seq andmiRNA-Seq - Proteomics
- 30 µL of human serum or plasma, in batches of at least 20 samples
- Integration
- Data from different omics platforms for the same samples
- Usage
- Olink Reveal is for research use only (RUO)
Mechanism of action
Which pathways does a compound activate or inhibit, and how does each model or cell type respond?
We compare treated and control samples to identify the genes, proteins, and pathways that account for a drug's effect.
How We Approach It
Study Design
- Design
- Every treatment, dose, or duration is a condition that must be managed
- Replies
- At least 3 biological replicates per treatment
- Models
- Cell cultures, animal models, and human samples
- Advice
- We'll work with you to determine the technique, depth, and number of replicas
Animal and cellular models
How do I characterize my preclinical models genetically and transcriptionally?
We sequence and analyze cell and animal models using the same procedures and controls across all batches.
How We Approach It
Study Design
- Species
- Humans and animals; for other species, please contact us
- Sample
- Tissue, cells, or nucleic acids that have already been extracted
- Extraction
- Optional, in our lab
- Lots
- The same procedures and controls for all batches
Studies on human samples
Which variants or molecular profiles are associated with a phenotype in my patient cohort?
We sequenced and analyzed cohorts, families, and tumor/control pairs—
—with the data protected as special-category data.
How We Approach It
Study Design
- Sample
- EDTA-anticoagulated blood, saliva, tissue, FFPE, or gDNA
- Input
- Exome ≥500 ng, DIN ≥7 (FFPE ≥200 ng) · Genome
PCR-Free ≥500 ng - Coverage
- Exome >100x · Genome 30x (90 Gb)
- Data
- Special category of data with enhanced safeguards
From Experimental Design to Results
- 1
Design
We'll work with you to determine the technique, the sequencing depth, and the number of replicates.
- 2
Exhibitions and bookstores
Quality control of samples and libraries using automated preparation on IVD-marked equipment.
- 3
Sequencing
Sequencing on an IVD-labeled platform with run and sample quality controls.
- 4
Analysis
Bioinformatics analysis of FASTQ files with interactive results on our Genome One Reports platform.
Learn About Genome One Reports
Tell us about your project
We'll get back to you with a technical proposal or a call from our scientific team.
- Response within 24 business hours
- Free review of the experimental design
- Option to sign an NDA before going into detail